Radiographic and the Esthetic Outcome of Two Different Bone Grafting Techniques in Early Implant Placement
A Comparative, Randomized, Prospective, Clinical Study to Evaluate the Facial Bone and Esthetic Outcome of Buccal Augmentation Bone Grafting Techniques in Early (Type 2) Implant Placement
1 other identifier
interventional
48
0 countries
N/A
Brief Summary
Total of 48 subjects were randomly assigned to treatment groups: UT Health Science Center at San Antonio Chi Mei Medical Center, Tainan, Taiwan Patients require a maxillary non-molar extraction site that is planned to be replaced by a dental implant and crown. This includes Straumann BL SLActive: Narrow (3.3mm) \& Regular (4.1mm) Crossfit implants in all available lengths. Patients were randomly selected to receive either FDBA (test) or Autogenous bone + DBBM (control/standard) for contour augmentation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2013
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2016
CompletedFirst Submitted
Initial submission to the registry
September 26, 2017
CompletedFirst Posted
Study publicly available on registry
October 4, 2017
CompletedOctober 4, 2017
September 1, 2017
2.8 years
September 26, 2017
September 29, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Facial bone thickness
Facial bone thickness 1 year post-loading at 1, 3, and 5mm from the implant platform
Measured at 1 year post-loading
Secondary Outcomes (5)
Change in facial bone thickness
Between implant placement and 1 year post-loading
mPI measurement
Measured at 6 and 12-months post-loading
PD measurement
Measured at 6 and 12-months post-loading
mSBI measurement
Measured at 6 and 12-months post-loading
KM measurement
Measured at 6 and 12-months post-loading
Study Arms (2)
Control
ACTIVE COMPARATORGuided bone regeneration with Bovine Bone Mineral
Experimental
EXPERIMENTALGuided bone regeneration with freeze dried bone allograft
Interventions
Guided bone regeneration with Bovine Bone Mineral
Guided bone regeneration with freeze dried bone allograft
Eligibility Criteria
You may qualify if:
- The patient is 18 years or older.
- Non-smoker or patient has smoking habit and \< 1 pack per day.
- Ability to understand and provide informed consent before starting the study.
- Ability and willingness to comply with all study requirements.
- The patient, if of child-bearing potential, has a negative urine pregnancy test.
- Adequate oral hygiene to allow for implant therapy consistent with standards of care.
- Adequate primary stability following early implant placement protocols utilizing Straumann Bone Level implants NC 3.3mm or RC 4.1mm in diameter at all available implant lengths.
- One or more teeth in maxilla (11,12,13,14,15,21,22,23,24,25 according to FDI) has been identified as having a hopeless prognosis requiring extraction leading to a single-tooth gap requiring implant placement as determined by clinician.
- Implant site that has a defect and requires bone augmentation. This will be determined by measuring on the CBCT image the available space for the implant and whether or not there is enough bone width where the implant is to be placed.
You may not qualify if:
- Patient reports current smoking habit \> 1 pack per day or tobacco chewing use.
- History of alcoholism or drug abuse within the past 5 years.
- Severe bruxism or clenching habits.
- Patient has significant untreated periodontal disease (grade III or IV), caries, or clinical or radiographic signs of infection within two adjacent tooth positions of implant area.
- History of HIV infection, Hepatitis B or C.
- Patients with a history of systemic disease that precludes standard dental implant therapy.
- Presence of local inflammation or mucosal diseases such as lichen planus
- Patient history consistent with high risk for subacute bacterial endocarditis
- Current hematological disorder or coumadin (or similar) therapy
- Patient currently undergoing chemotherapy
- Patient history of radiation treatment to the head or neck
- Physical or mental handicaps that would interfere with patient's ability to exercise good oral hygiene on a regular basis
- Pregnant or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2017
First Posted
October 4, 2017
Study Start
July 30, 2013
Primary Completion
May 15, 2016
Study Completion
May 15, 2016
Last Updated
October 4, 2017
Record last verified: 2017-09